Nanotechnology-Enabled Delivery Systems for Food Functionalization and Fortification

Nanotechnology Research Methods for Foods and Bioproducts

Volumn , Issue , 2012, Pages 55-101

  Tiwari, Rashmi ^a   Takhistov, Paul ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Antioxidant; Coacervate; Cochelate; Dendrimer; Functional food; Hydrogel; Liposome; Nanoemulsion; Nutraceutical; Omega 3 fatty acid; Phytochemical; Polymeric micelle; Proboitic bacteria

Indexed keywords

EID: 84881039401     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118229347.ch5     Document Type: Chapter

References (316)

1. asler, C.M. (1998) Functional foods: Their role in disease prevention and health promotion. Food Technology 52, 63-70.
2. Hasler, C.M. (2000) The changing face of functional foods. Journal of American College of Nutrition 19, 499S-506S.
3. Mitchell, E.A., Aman, M.G., Turbott, S.H. and Manku, M. (1987) Clinical characteristics and serum essential fatty acid levels in hyperactive children. Journal of Clinical Pediatrics 26, 406-411.
4. Wolfson, W. (2004) Fish oil cookies. Technology Reviews 27, 27.
5. BCC Research (2009) Nutraceuticals: Global markets and processing technologies. BCC Research, Wellesley. See http://www.bccresearch.com/report/nutraceuticals-processingmarkets- fod013c.html
6. Biesalski, H.K. (2001) Nutraceutical: The link between nutrition and medicine. In Nutraceuticals in Health and Disease Prevention of Toxicology (Kramer, K., Hoppe, P.P. and Packer, L., Eds), pp 1-26, Marcel Dekker Inc, New York.
7. Kris-Etherton, P.M., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski, A.E., Hilpert, K.F., Griel, A.E. and Etherton, T.D. (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. The American Journal of Medicine 113, 71S-88S.
8. Kramer, K., Hoppe, P. and Packer, L. (2001) Nutraceuticals in Health and Disease Prevention. Marcel Dekker Inc., New York.
9. Renner, E. (1988) Effects of agricultural practices on milk and dairy products. In Nutritional Evaluation of Food Processing (Karmas, E. and Harris, R.S., Eds), pp 203-224, Van Nostrand Reinhold, New York.
10. Krauss, W.E., Erb, J.H. and Washburn, R.G. (1933) Studies on the nutritive value of milk II. The effect of pasteurization on some of the nutritive properties of milk. The Journal of the American Medical Association 100, 2043-2044.
11. Sadler, G.D., Perish, M.E. and Wicker, L. (1992) Microbial, enzymatic and chemical changes during storage of fresh and processed orange. Journal of Food Science 57, 1187-1197.
12. Ilica, D.B. and Ashoor, S.H (1988) Stability of vitamins A and C in fortified yogurt. Journal of Dairy Science 71, 1492-1498.
13. Zhu, H. and Damodaran, S. (1994) Effects of calcium and magnesium ions on aggregation of whey protein isolate and its effect on foaming properties. Journal of Agriculture and Food Chemistry 42, 856-862.
14. Tatum, J.H., Philip, E.S. and Berry, R.E. (1969) Degradation products from ascorbic acid. Journal of Agricultural and Food Chemistry 17, 38-40.
15. Nagy, S., Rouseff, R.L., Fisher, J.F. and Lee, H.S. (1992) HPLC separation and spectral characterization of browning pigments from white grapefruit juice stored in glass and cans. Journal of Agricultural and Food Chemistry 40, 27.
16. Riberio, H.S., Ax, K. and Schubert, H. (2003) Stability of lycopene emulsions in food systems. Journal of Food Science 68, 2730-2734.
17. Aguilera, J.M. (2005) Why food microstructure. Journal of Food Engineering 67, 3-11.
18. Leser, M.E., Michael, M. and Watzke, H.J. (2003) Food goes nano: New horizons for food strucutre research. In Food Colloids: Biopolymers and Materials (Dickinson, E. and Vliet, T., Eds), pp 3-13, Royal Society of Chemistry, Cambridge.
19. Aguilera, J.M. (2000) Microstructure and food product engineering. Food Technology 54, 56-65.
20. Karla, E.K. (2003) Nutracetical: Definition and introduction. Journal of American Association of Pharmaceutical Scientists 5, 1-4.
21. Clemens, R. and Coughlin, J. (2007) Coffee and health: Surprisingly good news. Food Technology 1, 17-17.
22. Schacky, V.C., Angerer, P., Kothny, W., Theisen, K. and Mudra, H. (1999) The effect of dietary omega-3 fatty acids on coronary antherosclerosis. Annals of Internal Medicine 130, 554-562.
23. Burgess, J.R., Steven, L., Zhang, W. and Peck, L. (2000) Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 71, 327S-330S.
24. Murphy, D.J. and Underhill, M.I. (2007) Omega-3 fatty acid in pregnant women and infants. American Chiropractor 29, 16-20.
25. Blot, W.J., Chow, W.H. and McLaughlin, J.K. (1996) Tea and cancer: A review of the epidemiological evidence. European Journal of Cancer Prevention 5, 425-438.
26. Kohlmeier, L., Weterings, K.G.C., Stecks, S. and Kok, F.J. (1997) Tea and cancer prevention: An evaluation of epidemiological literature. Journal of Nutrition Cancer 27, 1-13.
27. Yu, N. (2008) Edible vaccines. Microbiology and Molecular Genetics 4, 104-109.
28. Nishino, H. (1997) Cancer prevention by natural carotenoids. Journal of Cellular Biochemistry 67, 86-91.
29. Agus, D.B., Gambhir, S.S., Pardridge, W.M., Spielholz, C., Baselga, J., Vera, J.C. and Golde, D.W. (1997) Vitamin C crosses the blood brain barrier in the oxidized form through the glucose transporters. Journal of Clinical Investigation 100, 2842-2848.
30. Rice-Evans, C.A., Miller, R.J. and Paganga, G. (1996) Structure antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology Medicine 20, 933-956.
31. Hertog, M.G.L. (1996) Epidemiological evidence of potential health properties of flavonoids. Processing of Nutrition Society 55, 385-397.
32. Gomes, D.C., Alegrio, L.V., Leon, L.I. and de Lima, M.E. (2002) Total synthesis and antileishmanial activity of some curcumin analogues. Arzneimittelforschung 52, 695-698.
33. Meydani, M. (2002) Antioxidants in the prevention of chronic diseases. Nutrition Clinical Care 5, 47-49.
34. Jialal, I. and Fuller, C.J. (1995) Effect of vitamin E,C and beta carotene on LDL oxidation and antheroslerosis. The Canadian Journal of Cardiology 11, 97G-103G.
35. McClements, D.J., Decker, E.A. and Weiss, J. (2007) Emulsion-based delivery systems for lipophilic bioactive components. Journal of Food Science 72, 109-124.
36. Vijayakumar, G.R. and Divakar, S. (2005) Synthesis of guaiacol-alpha-D-glucoside and curcumin-bis-alpha-D-glucoside by an amyloglucosidase from Rhizopus. Biotechnology Letter 27, 1411-1415.
37. Olthof, M.R., Hollman, P.C.H., Vree, T.B. and Katan, M.B. (2000) Bioavilabilities of quercetin-3-glucoside and quercetin-4-glucoside do not differ in humans. American Society of Nutritional Sciences 130, 1200-1203.
38. Xu, J.Z., Yeung, S.Y.V., Chang, Q., Huang, Y. and Chen, Z. (2004) Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. British Journal of Nutrition 91, 873-881.
39. Lee, M.J., Maliakal, P., Chen, L., Meng, X., Bondoc, F.Y., Prabhu, S., Lambert, G., Mohr, S. and Yang, C.S. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiology Biomarkers Prevention 11, 1025-1032.
40. Hix, L.M., Lockwood, S.F. and Bertram, J.S. (2004) Bioactive carotenoids: Potent antioxidants and regulators of gene expression. Redox Reports 9, 181-191.
41. Fielding, J.M., Li, D., Stockmann, R. and Sinclair, A.J. (2004) The effect of different plant oils used in preparing tomato sauces on plasma concentrations of lycopene and oxidative status: A dietary intervention study. Asia Pacific Journal of Clinical Nutrition 13, 1-5.
42. Bryant, J.D., McCord, J.D., Unlu, L.K. and Erdman, J.W. (1992) The isolation and partial characterization of alpha and beta-carotene carotenoprotein(s) from carrot (Dacus carota L) root chromoplasts. Journal of Agricultural and Food Chemistry 40, 545-549.
43. Kuhlbrandt, W., Wang, D.N. and Fujiyoshi, Y. (1994) Atomic model of plant lightharvesting complex by electron crystallography. Nature 367, 614-621.
44. Zhou, J.R., Gugger, E.T. and Erdman, J.W (1996) The crystalline form of carotenes and the food matrix in carrot root decrease the relative bioavailability of beta- and alphacarotene in the ferret model. Journal of the American College of Nutrition 15, 84-91.
45. Lichtenstein, A.H. and Jones, P.J. (2001) Lipids: Absorption and transport. In Present Knowledge in Nutrition (Bowman, B.A. and Russel, R.M., Eds), pp 93-103, ILSI Press, International Life Sciences Institute, Washington, D.C.
46. Donovan, J.L., Crespy, V., Manach, C., Morand, C., Besson, C., Scalbert, A. and Remsey, C. (2001) Catechin is metabolized by both the small intestine and liver of rats. American Society for Nutritional Sciences 131, 1753-1757.
47. Manach, C., Scalbert, A., Morand, C., Remsey, C. and Jimenez, L. (2004) Polyphenols: Food sources and bioavailability. American Journal of Clinical Nutrition 79, 727-747.
48. Petri, N., Tannergren, C., Holst, B., Mellon, F.A., Bao, Y., Plumb, G.W., Bacon, J., O'Leary, K.A., Kroon, P.A., Knutson, L., Forsell, P., Eriksson, T., Lennernas, H. and Williamson, G. (2003) Absorption/metabolism of sulforaphane and quercetin and regulation of phase II enzymes in human jejunam in vivo. Drug Metabolism and Disposition 31, 805-813.
49. Walle, U.K., Hsieh, F., Delegge, M.H. and Oatis, J.E. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32, 1377-1382.
50. Weiss, J., Takhistov, P. and McClements, J. (2006) Functional materials in food nanotechnology. Journal of Food Science 71, 107-116.
51. Richardson, D.P. and Ottaway, P.B. (1993) Food fortification. In The Technology of Vitamins in Food (Ottaway, P.B., Ed.), pp 233-244, Blackie Academic and Professional, Glasgow, Scotland.
52. Ottaway, P.B. (1993) Stability of vitamins in food. In The Technology of Vitamins in Food (Ottaway, P.B., Ed.), pp 90-112, Blackie Academic and Professional, Glasgow, Scotland.
53. Fennema, O.R., Parkin, K,L., Damodaran, S. (2004) Food Chemistry, 4th ed.. CRC Press, Boca Raton, FL.
54. Xianquan, S., Shi, J, Kakuda, Y. and Yueming, J. (2005) Stability of lycopene during food processing and storage. Journal of Medicinal Foods 8, 413-422.
55. Heinonen, M., Haila, K., Lampi, A,M. and Piironen, V. (1997) Inhibition of oxidation in 10% oil in water emulsions by beta-carotene with alpha- and gamma-tocopherols. Journal of the American Chemical Society 74, 1047-1052.
56. Patrasa, A., Bruntona, N.-P., O'Donnell, C. and Tiwari, B.K. (2010) Effect of thermal processing on anthocyanin stability in foods: Mechanisms and kinetics of degradation. Trends in Food Science & Technology 21, 3-11.
57. Sua, Y.L., Leunga, L.K., Huangb, Y. and Chen, Z. (2003) Stability of tea theaflavins and catechins. Food Chemistry 83, 189-195.
58. Chan, H.W.S. (1987) The mechanism of autoxidation. In Autoxidation of Unsaturated Lipids (Chan, H.W.S., Ed.), pp 1-16, Academic Press, London, UK.
59. Halliwell, B. and Chirico, S. (1993) Lipid peroxidation: Iits mechanism, measurement, and significance. The American Journal of Clinical Nutrition 57, 715S-725S.
60. Droge, W. (2002) Free radicals in the physiological control of cell function. Physiological Reviews 82, 47-95.
61. Frankel, E.N. (1984) Lipid oxidation: Mechanisms, products and biological significance. Journal of the American Oil Chemists' Society 61, 1908-1917.
62. Chen, C.C. and Wagner, G. (2004) Vtiamin E nanoparticle for beverage applications. Chemical Engineering Research Design 82, 1432-1437.
63. Gokhale, R. (2006) Food effect on drug formulation perfomance in vivo. Drug Delivery Technology 6, 62-72.
64. Mock, D.M. (1996) Biotin. In Present Knowledge in Nutrition (Ziegler, E.E. and Filer, L.J. Eds), pp 220-236, ILSI Press, Washington DC.
65. Stack, E.C., Smith, K.M. and Ryu, H. (2006) Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochemica Biophysica Acta 1762, 373-380.
66. Heck, A.M., DeWitt, B.A. and Lukes, A.L. (2000) Potential interactions between alternative therapies and warfarin. American journal of Health System Pharmacy 57, 1221-1227.
67. Somasundaram, S., Moore, E.A.N., Small, G.W., Shi, Y.Y. and Orlowski, R.Z. (2007) Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Research 62, 3868-3875.
68. Hendler, S.S. and Rorvik, D.R (2008) PDR for Nutritional Supplements, 2nd ed. Medical Economics Company, Inc, Montvale.
69. Hans, M.L. and Lowman, A.M. (2002) Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science 6, 319-327.
70. Lee, J. (2003) Drug nano and microparticles processed into solid dosage forms: Physical properties. Journal of Pharmaceutical Sciences 92, 2057-2068.
71. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J.X. and Kissel, T. (2000) Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? European Journal of Pharmaceutics and Biopharmaceutics 50, 147-160.
72. Sanders, N.N., Smedt, S.C., Rompaey, E.V., Simoens, P., Baets, F.D. and Demeester, J. (2000) Cystic fibrosis sputum: A barrier to the transport of nanospheres. American Journal of Respiratory Critical Care Medicine 162, 1905-1911.
73. Jani, P., Halbert, G.W., Langridge, J. and Florence, A.T. (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. The Journal of Pharmacy and Pharmacology 42, 821-826.
74. Hillery, A.M. (1998) Microparticulate delivery systems: Potential drug/vaccine carriers via mucosal routes. Pharmaceutical Science and Technology Today 1, 69-75.
75. Desai, M.P., Labhasetwar, V., Walter, E., Levy, R.J. and Amidon, G.L. (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharmaceutical Research 14, 1568-1573.
76. Panyam, J. and Labhasetwar, V. (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 55, 329-347.
77. Delie, F. (1998) Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Advanced Drug Delivery Reviews 34, 221-233.
78. Merisko-Livresidge, E., Liversidge G.G. and Cooper, E.R. (2003) Nanosizing: A formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences 18, 113-120.
79. Kreuter, J. (2001) Nanoparticulate systems for brain delivery of drugs. Advanced Drug Delivery Reviews 47, 65-81.
80. Moghimi, S.M., Murray, J.C. and Hunter, A.C. (2001) Long-circulating and target specific nanoaprticles: Theory to practice. Pharmacological Reviews 53, 283-318.
81. Nishioka, Y. and Yoshino, H. (2001) Lymphatic targeting with nanoparticulate sytems. Advanced Drug Delivery Reviews 47, 55-64.
82. Covreur, P. and Vauthier, C. (2006) Nanotechnology: Intelligent design to treat complex disease. Pharmaceutical Research 23, 1417-1450.
83. Lockman, P., Mumper, R., Khan, M. and Allen, D. (2002) Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Development and Industrial Pharmacy 28, 1-13.
84. Mbela, T.K.M., Poupaert, J.H. and Dumont, P. (1992) Poly(diethylmethylidene (malonate) nanoparticles as primaquine delivery system to liver. International Journal of Pharmaceuticals 79, 29-38.
85. Allemann, E., Gurny, R. and Doelker, E. (1993) Drug-loaded nanoparticles preparation method and drug targeting tissues. European Journal of Pharmaceuticas and Biopharmaceutics 39, 173-191.
86. Kreuter, J. (1983) Evaluation of nanoparticles as drug-delivery systems. III: Materials, stability, toxicity, possibilities of targeting, and use. Pharmaceutica Acta Helvetiae 58, 242-250.
87. Crandall, B.C. and Lewis, J. (1992) Nanotechnology: Research and Perspectives. MIT Press, Cambridge, MA.
88. Kayser, O., Lemke, A. and Hernandez-Trejo, N. (2005) The impact of nanobiotechnology on the development of new drug delivery systems. Current Pharmaceutical Biotechnology 6, 3-5.
89. Salata, O.V. (2004) Applications of nanoparticles in biology and medicine. Journal of Nanobiotechnology 2, 1-6.
90. Moghimi, S.M., Hunter, A.C. and Merray, J.C. (2005) Nanomedicine: Current status and future prospects. The FASEB Journal 19, 311-330.
91. Mehnert, W. and Mader, K. (2001) Solid lipid nanoparticles: Production, characterization and applications. Advanced Drug Delivery Reviews 47, 165-196.
92. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R. (1994) Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603.
93. Kwon, G.S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y. and Kataoka, K. (1995) Physical entrapment of adriamycin in AB block copolymer micelles. Pharmaceutical Research 12, 192-195.
94. Peracchia, M.T., Gref, R., Minamitake, Y., Domb, A., Lotan, N. and Langer, R. (1997) PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics. Journal of Controlled Release 46, 223-231.
95. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K. and Inoue, S. (1990) Characterization and anticancer activity of micelle-forming polymeric anticancer drug adryamycin-conjugated poly(ethylene glycol)-poly(asparatic acid) block copolymer. Cancer Research 50, 1693-1970.
96. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C. and Kataoka, K. (1991) Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Research 51, 3229-3236.
97. Pinto-Alphandary, H., Andermont, A. and Couvreur, P. (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: Reasearch and applications. International Journal of Antimicrobial Agents 13, 155-168.
98. Davda, J. and Labhasetwar, V. (2002) Characterization of nanoparticle uptake by endothelial cells. International Journal of Pharmaceutics 233, 51-59.
99. Florence, A.T. and Hussain, N. (2001) Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Advanced Drug Delivery Reviews 50, 69-89.
100. Lambert, G., Fattal, E. and Couvreur, P. (2001) Nanoparticulate systems for the delivery of antisense oligonucleotides. Advanced Drug Delivery Reviews 47, 99-112.
101. Mundargi, R.C., Babu, V.R., Rangaswamy, V., Patel, P. and Aminabhavi. T.M (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(D,Llactide- co-glycolide) and its derivatives. Journal of Control Release 125, 193-209.
102. Lockman, P.R., Mumper, R.J., Khan, M.A. and Allen, D.D. (2002) Nanoparticle technology for drug delivery across the blood brain barrier. Drug Development and Industrial Pharmacy 28, 1-13.
103. Davis, S.S. (1997) Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trends in Biotechnology 15, 217-224.
104. Kreuter, J. (1994) Drug targeting with nanoparticles. European Journal of Drug Metabolism and Pharmacokinetics 19, 253-256.
105. Gaur, U., Sahoo, S.K., De, T.K., Ghosh, P.C., Maitra, A.N. and Ghosh, P.K. (2000) Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. International Journal of Pharmaceuticals 202, 1-10.
106. Roberts, M.J., Bentley, M.D. and Harris, J.M. (2002) Chemistry of peptide and protein PEGylation. Advanced Drug Delivery Reviews 54, 459-476.
107. Douglas, S.J., Davis, S.S. and Illum, L. (1987) Nanoparticles in drug delivery. Critical Review in Therapeutic Drug Carrier System 3, 233-261.
108. Lacava, L.M., Lacava, Z.G., Da Silva, M.F., Silva, O., Chaves, S.B., Azevedo, R.B., Pelegrini, F., Gansau, C., Buske, N., Sabolovic, D. and Morais, P.C. (2001) Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophysics Journal 80, 2483-2486..
109. Brigger, I., Couvreur, P. and Dubernet, C. (2002) Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews 54, 631-651.
110. Ponchel, G. and Irache, J. (1998) Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Advanced Drug Delivery Reviews 34, 191-219.
111. Arbos, P., Arangoa, M.A., Campanero, M.A. and Irache, J.M. (2002) Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. International Journal of Pharmaceutics 242, 129-136.
112. Brannon-Peppas, L. and Blanchette, J.O. (2004) Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews 56, 1649-1659.
113. Roy, I., Ohulchanskyy, T.Y., Pdavar, H.E., Bergey, E.J., Oseroff, A.R., Morgan, J., Dougherty, T.J. and Prasad, P.N. (2003) Ceramic-based nanoparticles entrapping waterinsoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. Journal of American Chemical Society 125, 7860-7865.
114. Bangham, A.D., Standish, M.M. and Watkins, J.C. (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology 13, 238-252.
115. Hou, D.Z., Xie, C.S., Huang, K.J., Zhu, C.H. (2003) The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24, 1781-1785.
116. Gupta, A.K., Madan, S., Majumdar, D.K. and Maitra, A. (2000) Ketorolac entrapped in polymeric micelles: Preparation, characterization and ocular anti-inflammatory studies. International Journal of Pharmaceutics 209, 1-14.
117. Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A. and Puglisi, G. (2002) Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23, 3247-3255.
118. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., Rudzinski, W.E. (2001) Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70, 1-20.
119. Chen, H., Weiss, J. and Shahidi, F. (2006) Nanotechnology in nutraceuticals and functional foods. Food Technology 60, 30-36.
120. Mainardes, R.M. and Silva, L.P. (2004) Drug delivery systems: Ppast, present and future. Current Drug Targets 5, 449-455.
121. Sahoo, S.K. and Labhasetwar, V. (2003) Nanotech approaches to drug delivery and imaging. Drug Discovery Today 8, 1112-1120.
122. Chien, Y.W. (1990) Controlled- and modulated-release drug-delivery systems. In Encyclopedia of Pharmaceutical Technology (Swarbrick, J. and Boylan, J., Eds), pp 280-285, Marcel Dekker, Inc, New York.
123. Majeti, N.V. and Kumar, R. (2000) Nano and microparticles as controlled drug delivery devices. Journal of Pharmacology and Pharmaceutical Science 3, 234-258.
124. Uhrich, K.E., Thomas, T.., Laurencin, C.T. and Langer, R. (1997) In vitro degradation characteristics of poly(anhydride-imides) containing trimellitylimidoglycine. Journal of Applied Polymer Science 63, 1401-1411.
125. Liu, J., Meisner, D., Kwong, E., Wu, X.Y. and Johnston, M.R. (2009) Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Cancer Research 69, 1174-1181.
126. Freiberg, S. and Zhu, X.X. (2004) Polymer microspheres for controlled drug release. International Journal of Pharmaceutics 282, 1-18.
127. Langer, R. and Peppas, N.A. (2003) Advances in biomaterials, drug delivery, and bionanotechnology. AIChE Journal 49, 2990-3006.
128. Uhrich, K.E., Cannizzaro, S.M., Langer, R.S. and Shakesheff, K.M. (1999) Polymeric systems for controlled drug release. Chemical Reviews 99, 3181-3198.
129. Langer, R. (1993) Polymer controlled drug delivery system. Accounts of Chemical Research 26, 537-542.
130. Brayden, D.J. (2003) Controlled release technologies for drug delivery. Drug Discovery Today 8, 976-978.
131. Kabanov, A.V., Batrakova, E.V. and Alakhov, V.Y. (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 82, 189-212.
132. Lamprecht, A., Schäfer, U.F. and Lehr, C.M. (2001) Influences of process parameters on preparation of microparticle used as a carrier system for Ù-3 unsaturated fatty acid ethyl esters used in supplementary nutrition. Journal of Microencapsulation 18, 347-357.
133. Monsky, W.L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H.A., Torchilin, V. P., Yuan, F. and Jain, R.K. (1999) Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Research 59, 4129-4135.
134. Higuchi, T. and Davis, S.S. (1970) Thermodynamic analysis of structure activity relationships of drugs: Prediction of optimal structure. Journal of Pharmaceutical Science 59, 1376-1383.
135. Allen, T.M. and Cullis, P.R. (2004) Drug delivery systems: Entering the mainstream. Science 303, 1818-1822.
136. Roy, I., Mitra, S., Maitra, A. and Mozumdar, S. (2003) Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. International Journal of Pharmaceutics 250, 25-33.
137. Lemarchand, C., Gref, R. and Couvreur, P. (2004) Polysaccharide-decorated nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 58, 327-341.
138. Kobayashi, T., Sugimoto, T., Itoh, T., Kosaka, K., Tanaka, T., Suwa, S., Satoh, K. and Tsuji, K. (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35, 335-340.
139. Kobayashi, K. and Sumitomo, H. (1987) Synthesis and functions of polystyrene derivatives having pendant oligosaccharides. Polymer Journal 17, 567-565.
140. Cho, C., Kobayashi, A., Takei, R., Ishihara, T., Maruyama, A. and Akaike, T. (2001) Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 22, 45-51.
141. Alyautdin, R., Gothier, D., Petrov, V., Kharkevich, D. and Kreuter, J. (1995) Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 41, 44-48.
142. Kreuter, J., Langer, K., Weber, C. and Alyautdin, R.N. (2002) Nanoparticles made of protein with coupled apolipoprotein E for penetration of the blood-brain-barrier and methods for the production thereof. (Patent, E., Ed.). LOHMANN Therapie Systeme.
143. Clark, M.A., Hirst, B.H. and Jepson, M.A. (2000) Lectin-mediated mucosal delivery of drugs and microparticles. Advanced Drug Delivery Reviews 43, 207-223.
144. Russell-Jones, G.J., Veitch, H. and Arthur, L. (1999) Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. International Journal of Pharmaceutics 190, 165-174.
145. Goldstein, I.J., Hughes, R.C., Monsigny, M., Osawa, T. and Sharon, N. (1980) What should be called a lectin? Nature 285, 66.
146. Russel-Jones, G.J. and de Aizpurua, H.J. (1988) Vitamin B12: A novel carrier for orally presented antigens. Proceedings of International Symposium Control Release Bioactive Materials 15, 142-143.
147. Allen, T.M., Sapra, P. and Moase, E. (2002) Use of the post insertion method for the formation of ligand-coupled liposomes. Cellular and Molecular Biology Letters 7, 217-219.
148. Chilkoti, A., Dreher, M.R. and Meyer, D.E (2002) Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Advanced Drug Delivery Review 54, 1093-1111.
149. Mitra, S., Gaur, U., Ghosh, P.C. and Maitra, A.N. (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. Journal of Controlled Release 74, 317-323.
150. Allemann, E., Leroux, J. and Gurny, R. (1998) Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Advanced Drug Delivery Reviews 34, 171-189.
151. Sessa, G. and Weissmann, G. (1968) Phospholipid spherules (liposomes) as a model for biological membranes. Journal of Lipid Research 9, 310-318.
152. Bangham, A.D. and Horne, R.W. (1964) Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. Journal of Molecular Biology 8, 660-668.
153. Lasic, D. D (1993) Liposomes from Physics to Applications. Elsevier, Amsterdam.
154. Ostro, M.J. (1987) Liposomes from Biophysics to Therapeutics. Marcel Dekker, New York.
155. Barenholz, Y. (1993) Quality control of liposomes. Chemistry and Physics of Lipids 4, 1-2.
156. Er, Y., Prestidge, C.A. and Fornasiero, D. (2004) Attenuated total reflectance infrared studies of liposome adsorption at the solid-liquid interface. Colloids and Surfaces B: Biointerfaces 36, 147-153.
157. Grabielle-Madelmont, C., Lesieur, S. and Ollivon, M. (2003) Characterization of loaded liposomes by size exclusion chromatography. Journal of Biochemical and Biophysical Methods 56, 189-217.
158. Kozubek, A., Gubernator, J., Przeworska, E. and Stasiuk, M. (2000) Liposomal drug delivery, the novel approach; Plarosomes. Acta Biochim Polon 47, 639-649.
159. Woodle, W. and Papahadjopoulos, D. (1989) Liposome preparation and size characterization. Methods in Enzymology 171, 193-217.
160. Senior, J.H. (1987) Fate and behavior of liposomes in vivo: A review of controlling factors. Critical Review of Therapeutic Drug Carrier System 3, 123-193.
161. Allen, T. M. (1997) Liposomes: Opportunities in drug delivery. Drugs 54, 8-14.
162. Gabizona, A., Gorena, D., Cohenb, R. and Barenholz, Y. (1998) Development of liposomal anthracyclines: From basics to clinical applications. Journal of Control Release 53, 275-279.
163. Felnerova, D., Viret, J., Gluck, R. and Moser, C. (2004) Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Current Opinion in Biotechnology 15, 518-529.
164. Allen, T.M. and Chonn, A. (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. Federation of European Biochemical Societies 223, 42-46.
165. Gabizon, A. and Papahadjopoulos, D. (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of National Academy of the Sciences 85, 6949-6953.
166. Papahadjopoulos, D. and Gabizon, A. (1990) Liposomes designed to avoid the reticuloendothelial system. Progress in Clinical and Biological Research 343, 85-93.
167. Woodle, M.C., Engbers, C.M. and Zalipsky, S. (1994) New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconjugate Chemistry 5, 493-496.
168. Dagar, S., Krishnadas, A., Rubinstein, I., Blend, M.J. and Onyuksel, H. (2003) VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: In vivo studies. Journal of Controlled Release 91, 123-133.
169. Allen, T.M. (1994) Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends In Pharmacological Sciences 15, 215-220.
170. Hansen, C.B., Kao, G.Y., Moase, E.H., Zalipsky, S. and Allen, T.M. (1995) Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures. Biochimica et Biophysica Acta (BBA) - Biomembranes 1239, 133-144.
171. Yamazaki, N., Kodama, M. and Gabius, H.J. (1994) Neoglycoprotein-liposome and lectin-liposome conjugates as tools for carbohydrate recognition research. Methods in Enzymoloy 242, 56-65.
172. Feng, S., Ruan, G. and Li, Q. (2004) Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM). Biomaterials 25, 5181-5189.
173. Stenekes, R.J., Loebis, A.E., Fernandes, C.M., Crommelin, D.J. and Hennink, W.E. (2000) Controlled release of liposomes from biodegradable dextran microspheres: A novel delivery concept. Pharmaceutical Research 17, 690-695.
174. Behr, J. (1994) Gene transfer with synthetic cationic amphiphiles: Prospects for gene therapy. Bioconjugate Chemistry 5, 382-389.
175. Bhavane, R., Karathanasis, E. and Annapragada, A.V. (2003) Agglomerated vesicle technology: A new class of particles for controlled and modulated pulmonary drug delivery. Journal of Controlled Release 93, 15-28.
176. Okada, J., Cohen, S. and Langer, R. (1995) In vitro evaluation of polymerized liposomes as an oral drug delivery system. Pharmaceutical Research 12, 576-582.
177. Chen, H. and Langer, R. (1997) Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharmaceutical Research 14, 537-540.
178. Machluf, M., Apte, R.N., Regev, O. and Cohen, S. (2000) Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. Journal of Pharmaceutical Sciences 89, 1550-1557.
179. Moser, C., Metcalfe, I.C. and Viret, J.F. (2003) Virosomal adjuvanated antigen delivery systems. Expert Review Vaccines 2, 189-196.
180. Saraf, S., Saraf, S., Singh, R. and Gorde, N.K. (2007) Transferosomes: An overview. Pharmaceutical Reviews 5. See http://www.pharmainfo.net/reviews/transferosomesoverview
181. Patel, G.B. and Sprott, G.D. (1999) Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Critical Review in Biotechnology 9, 317-357.
182. Pandey, V.P. and Karthikeyan, D. (2008) Non-ionic surfactant based vesicle 'Niosome' as a potential ocular drug delivery system - An overview. Pharmainfo.net 6, 1.
183. Uchegbu, I.J. and Vyas, S.P. (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics 172, 33-70.
184. Parmar, M.M., Edwards, K. and Madden, T.D. (1999) Incorporation of bacterial membrane proteins into liposomes: Factors influencing protein reconstitution. Biochimica et Biophysica Acta (BBA) - Biomembranes 1421, 77-90.
185. Morais, P.C., Goncalves, G.R.R., Skeff Neto, K., Pelegrini, F. and Buske, N. (2002) Study of particle-particle interaction in magnetic fluids using magnetic resonance. IEEE Transactions on Magnetics 38, 3225-3227.
186. James, J. and Kullberg, M. (2006) A method for drug delivery using magnetoliposomes. Ethnicity & Disease 16, 5-10.
187. Nunes, S.M.T., Sguilla, F.S. and Tedesco, A.C. (2004) Photophysical studies of zinc phthalocyannine and chloroaluminium incorporated into liposomes in the presence of additives. Brazilian Journal of Medical and Biological Research 37, 273-284.
188. Prajapati, B.G. (2007) A review on PEGylated liposome in cancer therapy and in delivery of biomaterial. Pharmainfo.net 5, 1.
189. Tros de Ilarduya, C., Sun, Y. and Düzgüneş, N. (2010) Gene delivery by lipoplexes and polyplexes. European Journal of Pharmaceutical Sciences 40, 159-170.
190. Barratt, B. (2001) Therapeutic application of colloidal drug carriers. In Columbia Encyclopedia (Barratt, B., Ed.) 6th ed., Columbia University Press, New York.
191. Skeie, S. (1994) Developments in microencapsulation science applicable to cheese research and development. A review. International Dairy Journal 4, 573-595.
192. Lee, D.H., Jin, B.H., Hwang, Y.I. and Seung-Cheol-Lee, S.C. (2000) Encapsulation of bromelain in liposome. Journal of Food Science and Nutrition 5, 81-85.
193. Laridi, R., Kheadr, E.E., Benech, R.O., Vuillemard, J.C., Lacroix, C. and Fliss, I. (2003) Liposome encapsulated nisin Z: Optimization, stability and release during milk fermentation. International Dairy Journal 13, 325-336.
194. Kirby, C.J., Whittle, C.J., Rigby, N., Coxon, D.T. and Law, B.A. (1991) Stabilization of ascorbic acid by microencapsulation in liposomes. International Journal of Food Science & Technology 26, 437-449.
195. Singh, H. (2006) The milk fat globule membrane: A biophysical system for food applications. Current Opinion in Colloids and Interface Science 11, 154-163.
196. Zarif, L., Graybill, Jr., Perlin, D. and Mannino, R.J. (2000) Cochleates new lipid based drug delivery system. Journal of Liposome Research 10, 523.
197. Papahadjopoulos, D., Vail, W.J., Jacobson, K. and Poste, G. (1975) Cochleate lipid cylinders: Formation by fusion of unilamellar lipid vesicles. Biochimica Biophysica Acta 394, 483-490.
198. Gould-Fogerite, S., Kheiri, M.T., Zhang, F., Wang, Z., Scolpino, A.J., Feketeova, E., Canki, M. and Mannino, R.J. (1998) Targeting immune response induction with cochleate and liposome-based vaccines. Advanced Drug Delivery Reviews 32, 273-287.
199. Jansen, J.F., de Brabender, V., Ellen, M.M. and Meijer, E.W. (1994) Encapsulation of guest molecules into a dendritic box., Science 266, 1226-1229.
200. Joseph, T. and Morrison, M. (2006) Nanotechnology in Agriculture and Food: A Nanoforum Report. Institute of Nanotechnology.
201. Etcgroup (2004) Down on the Farm: The Impact of Nano-Scale Technologies on Food and Agriculture. Etcgroup.
202. Kamath, K. and Park, K. (1993) Biodegradable hydrogels in drug delivery. Advance Drug Delivery Review 11, 59-84.
203. Peppas, N.A. and Lowman, A.M. (1999) Hydrogels. John Wiley & Sons, New York.
204. Qiu, Y. and Park, K. (2001) Environment-sensitive hydrogels for drug delivery. Advanced Drug Delivery Reviews 53, 321-339.
205. Lee, V.H.L., Hashida, M. and Mizushima, Y (1995) Trends and Future Perspectives in Peptide and Protein Drug Delivery. Harwood Academic Publishers, The Netherlands.
206. Peppas, N.A., Bures, P., Leobandung, W. and Ichikawa, H. (2000) Hydrogels in pharmaceutical formulation. European Journal of Pharmaceutics and Biopharmaceutics 50, 27-46.
207. Fix, J. A. (1996) Oral controlied release technology for peptides: Status and future prospects. Pharmaceutical Research 13, 1760-1764.
208. Plate, N.A., Valuev, L.1., Starosel'tseva, L.K., Valueva, T.A., Vanchugova, L.V., UI'yanova, M.V., Valuev, I.L., Sytov, G.A., Ametov, A.S. and Knyazhev, V, A. (1994) Macromolecular systems containing insulin as related to the problem of diabetes. Polymer Science 36, 1581-1585.
209. Kopece, J., Kopeckova, P. and Omelyanenko, V. (1996) Biorecognizable biomedical polymers: Advanced biomaterials. In Biomedical and Drug Delivery Systems, (Ogata, N., Kim, S, W, Feijen, J., Okano, T, Ed.), pp 91-95,Springer, Tokyo.
210. Park, K. and Park, H. (1999) Smart hydrogels, In Concise Polymeric Materials Encyclopedia (Salamone, J. C, Ed.), pp 1476-1478, CRC Press, Boca Raton.
211. Peppas, N.A. and Sahlin, J.J. (1996) Hydrogels as muco- and bioadhesive materials: A review. Biomaterials 17, 1553-1561.
212. Podula, K., Doyle III, F.J. and Peppas, N.A. (2000) Glucose-sensitivity of glucose oxidase containing cationic copolymer hydrogels having poly (ethylene glycol) grafts. Journal of Controlled Release 67, 9-17.
213. Sahoo, S.K., Tapas, K.D., Ghosh, P.K. and Maitra, A. (1998) PH and thermosensitive hydrogels nanoparticles. Journal of Colloid and Interface Sciences 206, 361-368.
214. Chen, L., Remondetto, G.E. and Subirade, M. (2006) Food protein based materials as nutraceutical delivery systems. Trends in Food Science and Technology 17, 272-283.
215. Leung, S.V., Remondetto, G.E. and Subirade, M. (2005) Cold gelation of ß- lactoglobulin oil-in-water emulsions. Food Hydrocolloids 19, 269-278.
216. Kwon, G.S. and Okano, T. (1996) Polymeric micelles as new drug carriers. Advanced Drug Delivery Review 21, 107-116.
217. Attwood, D. and Florence, A.T. (1983) Surfactant Systems: Their Chemistry, Pharmacy and Biology, 1st ed. Chapman and Hall, London.
218. Rosler, A., Vandermeulen, G.W.M. and Klok, H.A. (2001) Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Advanced Drug Delivery Reviews 53, 95-108.
219. Yasugi, K., Nakamura, T., Nagasaki, Y., Kato, M. and Kataoka, K. (1999) Sugarinstalled polymer micelles: Synthesis and micellization of poly(ethylene glycol)-poly (,-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 32, 8024-8032.
220. Trubetskoy, V.S. and Burke, T.J. (2005) Engineered polymeric micelles: A novel tool for solubiliation and stabilization of membrane protein target for proteomics and drug discovery, American Laboratory 37, 19-22.
221. Kakizawa, Y., Harada, A. and Kataoka, K. (2001) Glutathione-sensitive stabilisation of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(-lysine): A potential carrier for systemic delivery of antisense DNA. Biomacromolecules 2, 491-497.
222. Trubetskoy, V.S. and Torchilin, V.P. (1996) Polyethyleneglycol based micelles as carriers of therapeutic and diagnostic agents. Pharma Sciences 6, 79-86.
223. Kataoka, K., Togawa, H., Harada, A., Yasugi, K., Matsumoto, T. and Katayose, S. (1996) Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 29, 8556-8557.
224. Katayose, S. and Kataoka, K. (1998) Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly ( -lysine) block copolymer. Journal of Pharmaceutical Science 87, 160-163.
225. Katayose, S. and Kataoka, K. (1997) Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjugate Chemistry 8, 702-707.
226. Trubetskoy, V. S., Gazelle, G.S., Wolf, G.L. and Torchilin, P. (1997) Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: Design of a long circulating particulate contrast medium for X-ray computed tomography. Journal of Drug Targeting 4, 381-388.
227. Jones, M. and Leroux, J. (1999) Polymeric micelles - a new generation of colloidal drug carriers. European Journal of Pharmaceutics and Biopharmaceutics 48, 101-111.
228. Tomalia, D.A., Naylor, A.M. and Goddard III, W.A. (1990) Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angewandte Chemie International Edition in English 102, 138-175.
229. Aulenta, F., Hayes, W. and Rannard, S. (2003) Dendrimers: A new class of nanoscopic containers and delivery devices. European Polymer Journal 39, 1741-1771.
230. Hawker, C.J. and Frechet, J.M.J. (1996) Comparison of linear, hyperbranched, and dendritic macromolecules. In Step-Growth Polymers for High-Performance Materials (Hedrick, J. and Labadie, J., Eds), pp 132-144, American Chemical Society, Washington D.C.
231. Liu, S. and Armes, S.P. (2001) Recent advances in the synthesis of polymeric surfactants. Current Opinion in Colloid & Interface Science 6, 249-256.
232. Kohn, J. (1993) Design, synthesis, and possible applications of pseudo-poly(amino acids). Trends in Polymer Science 17, 206-212.
233. Nathan, N., Zalipsky, S. and Kohn, J. (1994) Strategies for covalent attachment of doxorubicin to poly(PEG-Lys), a new water-soluble poly(ether urethane). Journal of Bioactive and Compatible Polymers 9, 239-251.
234. Purohit, G., Sakthivel, T. and Florence, A.T. (2001) Interaction of cationic partial dendrimers with charged and neutral liposomes. International Journal of Pharmaceutics 214, 71-76.
235. Khopade, A.J., Caruso, F., Tripathi, P., Nagaich, S., Jain, N.K. (2002) Effect of dendrimer on entrapment and release of bioactive from liposomes. International Journal of Pharmaceutics 232, 157-162.
236. Sarbolouki, M.N., Sadeghizadeh, M., Yaghoobi, M.M., Karami, A. and Lohrasbi, T. (2000) Dendrosomes: A novel family of vehicles for transfection and therapy. Journal of Chemical Technology and Biotechnology 75, 919-922.
237. Haensler, J. and Szoka, F.C. (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chemistry 4, 372-379.
238. Zhuo, R.X., Du, B. and Lu, Z.R. (1999) In vitro release of 5-fluorouracil with cyclic core dendritic polymer. Journal of Controlled Release 57, 249-257.
239. Bhadra, D., Bhadra, S.,Jain, P. and Jain, N.K. (2002) Pegnology: A review of PEGylated systems. Pharmazie 57, 5-29.
240. Bhadra, D., Bhadra, S., Jain, S. and Jain, N.K. (2003) A PEGylated dendritic nanoparticulate carrier of fluorouracil. International Journal of Pharmaceutics 257, 111-124.
241. Veronese, F.M., Caliceti, P., Pastorino, A., Schiavon, O., Sartore, L., Banci, L. and Scolaro, L.M. (1989) Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase. Journal of Controlled Release 10, 145154.
242. Jansen, J., Debrabandervandenberg, E. M.M. and Meijer, E.W. (1994) Encapsulation of guest molecules into a dendritic box. Science 266, 1226-1229.
243. Klajnert, B. and Bryszewska, M. (2001) Dendrimers: Properties and applications. Acta Biochimica Polonica 48, 199-208.
244. Liu, M.J., Kono, K. and Frechet, J.M.J. (2000) Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. Journal of Controlled Release 65, 121-131.
245. Couvreur, P., Couarraze, G., Devissaguet, J.P. and Puisieux, F. (1996) Nanoparticles: Preparation and Characterization. Marcel Dekker, New York.
246. Fattal, E., Vauthier, C., Aynie, I., Nakada, Y., Lambert, G., Malvy, C. and Couvreur, P. (1998) Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Journal of Controlled Release 53, 137-143.
247. Barratt, B. (2000) Therapeutic applications of colloidal drug carriers. Pharmaceutical Science & Technology Today 3, 163-171.
248. Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A. and Couvreur, P. (2000) Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharmaceutical Research 17, 707-714.
249. Godard, G., Boutorine, A.S., Saison-Behmoaras, E. and Helene, C. (1995) Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly (alkylcyanoacrylate) nanoparticles. European Journal of Biochemistry 232, 404-410.
250. Schwab, G., Chavany, C., Duroux, I., Goubin, G., Lebeau, J., Helene, C. and Saison- Behmoaras, T. (1994) Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proceedings of the National Academy of Sciences of the United States of America 91, 10460-10464.
251. Zimmer, A. (1999) Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods 18, 286-295.
252. Storm, G., Belliot, S.O., Daemen, T. and Lasic, D.D. (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Advanced Drug Delivery Reviews 17, 31-48.
253. Sharma, D., Chelvi, T.P., Kaur, J., Chakravorty, K., De, T.K., Maitra, A.N. and Ralhan, R. (1996) Novel Taxol formulation: Polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy. Oncology Research 7-8, 281-286.
254. Stolnik, S., Illum, L. and Davis, S.S. (1995) Long circulating microparticulate drug carriers. Advanced Drug Delivery Review 16, 195-214.
255. Rodrigues, J.S., Santos-Magalhaes, N.S., Coelho, L.C.B.B., Couvreur, P., Ponchel, G. and Gref, R. (2003) Novel core(polyester)-shell(polysaccharide) nanoparticles: Protein loading and surface modification with lectins. Journal of Controlled Release 92, 103-112.
256. Leroux, J.C., Allemann, E., Jaeghere, F.D., Doelker, E. and Gurny, R. (1996) Biodegradable nanoparticles: From sustained release formulations to improved site specific drug delivery. Journal of Controlled Release 39, 339-350.
257. Duncan, R. (1992) Drug-polymer conjugates: Potential for improved chemotherapy. Anti-Cancer Drugs 3, 175-210.
258. Dickinson, E. and McClements, D.J. (1995) Advances in Food Colloids, 1st ed. Blackie Academic and Professional, Glasgow.
259. Coupland, J.N. and McClements, D.J. (2001) Droplet size determination in food emulsions: Comparison of ultrasonic and light scattering methods. Journal of Food Engineering 50, 117-120.
260. Dickinson, E. (1992) Introduction to Food Colloids. Oxford University Press, Oxford.
261. McClements, D.J. (2005) Food emulsions: Principles, Practice, and Techniques. CRC Press, Boca Raton.
262. Muller, R.H. and Keck, C.M. (2004) Challenges and solutions for the delivery of biotech drugs: A review of drug nanocrystal technology and lipid nanoparticles. Journal of Biotechnology 113, 151-170.
263. Nakano, M. (2000) Places of emulsions in drug delivery. Advance Drug Delivery Review 45, 1-4.
264. Benichou, A., Aserin, A. and Garti, N. (2004) Double emulsions stabilized with hybrids of natural polymers for entrapment and slow release of active matters. Advances in Colloid and Interface Science 108-109, 29-41.
265. Garti, N. and Benichou, A. (2001) Double Emulsions for Controlled-release Applications: Progress and Trends. Marcel Dekker, Inc.
266. Lawson, L.B. and Papadopoulos, K.D. (2004) Effects of a phospholipid cosurfactant on external coalescence in water-in-oil-in-water double-emulsion globules. Colloids and Surfaces A: Physicochem. Eng. Aspects 250, 337-342.
267. Müller, R.H., Rühl, D., Runge, S.A., Schulze-Forster, K. and Mehnert, W. (1997a) Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharmaceutical Research 14, 458-462.
268. Müller, R.H., Maaßen, S., Schwarz, C. and Mehnert, W. (1997b) Solid lipid nanoparticles (SLN) as potential carriers for human use: Interaction with human granulocytes. Journal of Controlled Release 47, 261-269.
269. Gasco, M.R. (1997) Solid lipid nanospheres from warm micro-emulsions. Pharmaceutical Technology Europre 9, 56-58.
270. Heiati, H., Phillips, N.C. and Tawashi, R. (1996) Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharmaceutical Research 13, 1406-1410.
271. Mukherjee, S., Ray, S. and Thakur, R.S. (2009) Solid lipid nanoparticles: A modern formulation approach in drug delivery systems. Indian Journal of Pharmaceutical Science 71, 349-358.
272. Muller, R.H., Mehnert, W., Lucks, J.S., Schwarz, C., Zur Muhlena, A., Meyhers, H., Freitas, C. and Ruhl, D. (1995) Solid lipid nanoparticles (SLN): An alternative colloidal carrier system for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 41, 62-69.
273. Schwarz, C. and Mehnert, W. (1999) Solid lipis nanoparticles for controlled drug delivery II. Drug incorporation and physicochemical characterization. Journal of Microencapsulation 16, 205-213.
274. Tabatta, K., Kneuerb, C., Sametic, M., Olbricha, C., Müllera, R.H., Lehrc, C. and Bakowsky, U. (2004) Transfection with different colloidal systems: Comparison of solid lipid nanoparticles and liposomes. Journal of Controlled Release 97, 321-332.
275. Tabatta, K., Sameti, M., Olbrich, C., Müller, R.H. and Lehr, C.M. (2004) Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. European Journal of Pharmaceutics and Biopharmaceutics 57, 155-162.
276. Uner, M. (2006) Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems. Pharmazie 61, 375-386.
277. Muller, R. H., Radtke, M. and Wissing, S.A. (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Review 54, S131-155.
278. Radtke, M. and Muller, R.H. (2000) Comparison of structural properties of solid lipid nanoparticles (SLN) versus other lipid particles. Proceedings of International Symposium Control Release Bioactive Materials 27, 309-210.
279. Müller, R.H., Mäder, K. and Gohla, S. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art. European Journal of Pharmaceuticas and Biopharmaceutics 50, 161-177.
280. Müller, R.H., Mäder, K., Lippacher, A. and Jenning, V. (2000) Solid-lipid (semi-solid) liquid particles and method of producing highly concentrated particles dispersions. German Patent Application, 199 45 203-222
281. Olbrich, C., Gessner, A., Kayser, O. and Müller, R.H. (2002) Lipid-drug-conjugate (LDC) nanoparticles as a novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. Journal of Drug Targeting 10, 387-396.
282. Bakan, J.A. (1980) Microencapsulation using coacervation/phase separation technique. In Controlled Release Technology: Methods, Theory and Applications (Kydonieux, A.F., Ed.), pp 84-104, CRC Press, Boca Raton.
283. Burgess, J.E. and Carless, D.J. (1984) Microelectrophoretic studies of gelatin and acacia for the prediction of complex coacervation. Journal of Colloid and Interfacial Science 98, 1-8.
284. Dervichian, D.G. (1954) A comparative study of the flocculation and coacervation of different systems. Discussion of the Faraday Society 18, 231-239.
285. Dobetti, L. and Pantaleo, V. (2002) Application of a hydrodynamic model to microencapsulation by coacervation. Journal of Microencapsulation 19, 139-151.
286. Prokop, A., Hunkeler, D., DiMaris, S., Haralsom, M.A. and Wang, T.G. (1998) Water soluble polymers for immunolisation I: Complex coacervation and cytotoxicity. Advanced Polymer Science 136, 1-51.
287. Korus, J., Tomasik, P. and Lii, C.Y. (2003) Microcapsules from starch granules. Journal of Microencapsulation 20, 47-56.
288. Dubin, P.L., Muhoberac, B.B. and Xia, J. (1998) Preparation of Enzyme-Polyelectrolyte Coacervate Complexes and their Properties. Patent number: US 5834271A.
289. Junyaprasret, M., Mitrevej, A., Sinchaipand, N., Boonme, P. and Wurster, D.E. (2001) Effect of process variables on the microencapsulation of vitamin and palmitate by gelatin acacia coacervation. Drug Delivery and Industrial Pharmacy 26, 561-566.
290. Strauss, G. and Gibson, S.M. (2004) Plant phenolics as cross-linkers of gelatin gels and gelatin-based coacervates for use as food ingredients. Food Hydrocolloids 18, 81-89.
291. Yeo, Y., Bellas, E., Firestone, W., Langer, R. and Kohane, D.S. (2005) Complex coacervates for thermally sensitive controlled release of flavor compounds. Journal of Agriculture and Food Chemistry 53, 7518-7525.
292. Gouin, S. (2004) Micro encapsulation industrial appraisal of existing technologies and trends. Trends in Food Science and Technology 15, 330-347.
293. Rabinow, B.E. (2004) Nanosuspensions in drug delivery. Nature Reviews Drug Discovery 3, 785-796.
294. Muller, R.H., Jacobs, C. and Kayser, O. (2001) Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future. Advanced Drug Delivery Reviews 47, 3-19.
295. Liversidge, G.G. and Cundy K.C. (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. International Journal of Pharmaceuticals 125, 91-97.
296. Sarkari, M., Brown, J., Chen, X.X., Swinnea, S., Williams, R.O. and Johnston, K.P. (2002) Enhanced drug dissolution using evaporative precipitation into aqueous solution. International Journal of Pharmaceuticals 243, 1731.
297. Grau, M. J., Kayser, O. and Muller, R.H. (2000) Nanosuspensions of poorly soluble drugs - reproducibility of small scale production. International Journal of Pharmaceutics 196, 155-159.
298. Jia, L., Wong, H., Cerna, C. and Weitman, S.D. (2002) Effect of nanonization on absorption of 301029: Ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharmaceutical Research 19, 1091-1096.
299. Dinsmore, A.D., Hsu, M.F., Nikolaides, M.G., Marquez, M., Bausch, A.R. and Weitz, D.A (2002) Colloidosomes: Selectively permeable capsules composed of colloidal particles. Science 298, 1006-1009.
300. Saraf, S., Rathi, R., Kaur, D. and Saraf, S. (2011) Colloidosomes: An advanced vesicular system in drug delivery. Asian Journal of Science Alert 4, 1-15.
301. Noble, P.F., Cayre, O.J., Alargova, R.G., Velev, O.D. and Paunov, V.N. (2004) Fabrication of hairy colloidosomes with shells of polymeric microrods. Journal of American Chemical Society 126, 8092-8093.
302. Shilpi, S., Jain, A., Gupta, Y. and Jain, S.K. (2007) Colloidosomes: An emerging vesicular system in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 24, 361-391.
303. Saraf, S. (2008) Aquasomes: An overview. Pharmaceutical Information 6. See http:// www.pharmainfo.net/reviews/aquasomes-overview
304. Shahabade, S.G., Bhosale A.V., Mutha S.S., Bhosale N.R., Khade P.H., Bhadane N.P. and Shinde S.T. (2009) An overview on nanocarrier technology: Aquasomes. Journal of Pharmacy Research 2, 1174-1177.
305. Kossovsky, N., Gelman, A., Rajguru, S., Nguyen, R., Sponsler, E., Hnatyszyn, H.J., Chow, K., Chung, A., Torres, M. and Zemanovich, J. (1996) Control of molecular polymorphisms by a structured carbohydrate/ceramic delivery vehicle - aquasomes. Journal of Control Release 39, 383-388.
306. Spicer, P. T ( 2009) Cubosomes: Bicontinuous liquid crystalline nanoparticles. In Dekker Encyclopedia of Nanoscience and Nanotechnology (Contescu, C.I. and Putyera, K., Eds), pp 1018-1028, CRC Press, Boca Raton.
307. Borne, J., Naylander, T. and Khan, A. (2002) Effect of lipase on onoolein-based cubic phase dispersion (cubosomes) and vesicles. Journal of Physical Chemistry B 106, 10492-10500.
308. Caruso, F., Caruso, R. and Möhwald, H. (1998) Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating. Science 282, 1111-1114.
309. Cherian, A.K., Rana, A.C. and Jain, S.K (2000) Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Development and Industrial Pharmacy 26, 459-463.
310. Jain, T.K., Roy, I., De, T.K. and Maitra, A. (1998) Nanometer silica particles encapsulating active compounds: A novel ceramic drug carrier. Journal of American Chemical Society 120, 11092-11095.
311. Lal, M., Levy, L., Kim, K.S., He, G.S., Wang, X., Min, Y.H., Pakatchi, S. and Prasad, P.N. (2000) Silica nanobubbles containing an organic dye in a multilayered organic/inorganic heterostructure with enhanced luminescence. Chemical Matters 12, 2632-2639.
312. Badley, R.D., Ford, W.T., McEnroe, F.J. and Assink, R.A. (1990) Surface modification of colloidal silica. Langmuir 6, 792-801.
313. Sukhorukov, G.B., Rogach, A.L., Zebli, B., Liedl, T., Skirtach, A.G., Köhler, K., Antipov, A.A., Gaponik, N., Susha, A.S., Winterhalter, M. and Parak, W.J. (2005) Nanoengineered polymer capsules: Tools for detection, controlled delivery and sitespecific manipulation. Small 1, 194-200.
314. Martin, C.R. and Kohli, P. (2004) The emerging field of nanotube biotechnology. Nature Review of Drug Discovery 2, 29-37.
315. Goldstein, A.S., Amory, J.K., Martin, S.M., Vernon, C., Matsumoto, A.M. and Yager, P. (2001) Testosterone delivery using glutamide based complex high axial ratio microstructures. Bioorganic and Medicinal Chemistry 9, 2819-2825.
316. Ram Rao, C.N. and Govindaraj, A (2005) Nanotubes and Nanowires. RSC Publishing.